Surge personalizes the care of patients undergoing surgery by providing an accurate prediction of postoperative infections.
Surge has raised $5.7M in total funding. The most recent round was Seed. The last funding was announced in March 2024.
Surge's investors include Bpifrance, Eurazeo, Kima Ventures, HCVC, Teampact ventures.
Surge is headquartered in Illkirch-graffenstaden, France.
Surge personalizes the care of patients undergoing surgery by providing an accurate prediction of postoperative infections.
Surge is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Surge — Funding & Investors." VCBacked, March 27, 2024, https://www.vcbacked.co/company/surge-illkirch-graffenstaden. Accessed July 20, 2026.
VCBacked. (2024). Surge — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/surge-illkirch-graffenstaden
{{cite web |title=Surge — Funding & Investors |url=https://www.vcbacked.co/company/surge-illkirch-graffenstaden |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated